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Abstract
Background: During production and processing of multi-walled carbon nanotubes (MWCNTs), they may be
inhaled and may enter the pulmonary circulation. It is essential that interactions with involved body fluids like the
pulmonary surfactant, the blood and others are investigated, particularly as these interactions could lead to coating
of the tubes and may affect their chemical and physical characteristics. The aim of this study was to characterize
the possible coatings of different functionalized MWCNTs in a cell free environment.
Results: To simulate the first contact in the lung, the tubes were coated with pulmonary surfactant and
subsequently bound lipids were characterized. The further coating in the blood circulation was simulated by
incubating the tubes in blood plasma. MWCNTs were amino (NH2)- and carboxyl (-COOH)-modified, in order to
investigate the influence on the bound lipid and protein patterns. It was shown that surfactant lipids bind
unspecifically to different functionalized MWCNTs, in contrast to the blood plasma proteins which showed
characteristic binding patterns. Patterns of bound surfactant lipids were altered after a subsequent incubation in
blood plasma. In addition, it was found that bound plasma protein patterns were altered when MWCNTs were
previously coated with pulmonary surfactant.
Conclusions: A pulmonary surfactant coating and the functionalization of MWCNTs have both the potential to
alter the MWCNTs blood plasma protein coating and to determine their properties and behaviour in biological
systems.
Background
Carbon nanotubes (CNTs), discovered in the early
1990’s [1], have been brought into focus due to their
outstanding mechanical, electronic, optical and magnetic
properties. In a rapidly growing field, numerous new
applications have been developed and the need for
CNTs has reached industrial production scale [2]. How-
ever, the exposure risks during the processing and pro-
duction of CNTs has also increased substantially. It is
known from studies with nano-sized particles [3] and
CNTs [4,5] that exposure by inhalation is the primary
exposure route for humans.
Due to their size and shape, inhaled CNTs may reach
the alveolar region [6,7]. Upon deposition, they come in
initial contact with the pulmonary surfactant, which is
located at the air-liquid interface. Surfactant contains
85-90% phospholipids [8] and has an essential function
during breathing by reducing the surface tension [9].
Adsorption of pulmonary surfactant phospholipids was
shown on nano-sized gold particles [10] and on carbon
black nano-sized particles [11]. In contrast, interactions
of CNTs with complex mixtures of pulmonary surfac-
tant lipids have not been studied in detail so far.
By wetting forces, nano-sized particles are displaced
into the hypophase [12-14] and may be translocated
across the air-blood tissue barrier by crossing the
epithelium, the basal membrane and the endothelium
[15]. Once in the blood circulation they may reach sec-
ondary organs [16]. A study recently demonstrated in an
overload situation that inhaled CNTs were able to reach
the subpleura in mice and were inducing subpleural
fibrosis [17]. Thus inhaled particles firstly get in contact
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with surfactant and body fluids and will interact as
coated particles with tissue [13]. In the blood circula-
tion, CNTs encounter approximately 7000 proteins and
isoforms [18,19] which can bind to them, as it has been
shown in the literature [20-22]. Investigations of these
bound components are essential, as it is not the particle
itself that defines the biological active identity. Moreover
it is a dynamic interplay of associating and dissociating
biomolecules [23,24], which is an entity known as the
particles “corona”. This biomolecule-particle interplay is
governed by a large variety of influencing factors from
which the very fundamentals are the characteristics of
the nano-sized particle itself and the characteristics of
the surrounding media.
Among others (like the crystallinity or the shape), the
surface functionalization is considered to be one of the
most important characteristics of nano-sized particles
[25]. By functionalization (i.e. by modifying the surface)
a material exhibits new physical, chemical and biological
characteristics. To make the surface negatively or posi-
tively charged, carboxyl or amino groups can be cova-
lently attached. Characteristic patterns of bound plasma
proteins have been shown with carboxyl- and amino-
modified polystyrene particles [26,27]. Additionally, it
was demonstrated for CNTs that the protein binding
was reduced or altered after functionalization [22,28,29].
However, inherent properties of the surrounding med-
ium such as the presence of organic molecules (e.g. pro-
teins) or detergents [25] also strongly determine the
binding characteristics and result in new properties of
the particle-biomolecule complex. The binding of pro-
teins on a nano-sized particle can change the proteins
native conformation [23,30] and may result in the pre-
sentation of novel epitopes [30,31]. The new complex
triggers (inappropriate) cellular signaling [32,33], initiate
protein fibrillation [34], may undergo new transport
mechanisms or may be opsonized by the mononuclear
phagocytic system [35]. The presence of such opsonins
on the particles surface creates a “molecular signature”
which may affect the eventual fate of the nano-sized
particles in the body [13,36] or have implications on the
particles adverse effects [23]. Thus for a detailed
understanding of the CNT - cell interaction, a careful
assessment of the adsorbed biomolecules has to be
included.
The aim of this study was to characterize the binding
of biomolecules to different functionalized MWCNTs to
simulate their entry into the blood circulation, in a cell
free system. From current knowledge, it was not yet con-
sidered that inhaled CNTs get in contact with pulmonary
surfactant prior to serum proteins. Thus it was of central
interest to investigate if the presence of this surfactant
alters the protein binding later in the bloodstream and to
investigate if the initially bound biomolecules (in particu-
lar the surfactant lipids) are exchanged due to dynamic
processes.
Results and discussion
Pristine MWCNTs (P-MWCNTs) and MWCNTs func-
tionalized with positively (-NH2) and negatively
(-COOH) charged side groups were characterized with
different coatings (Table 1). The first coating, which
should simulate an initial encounter of MWCNTs with
a biological structure in the lung, was investigated by
characterizing CNT-bound surfactant lipids. MWCNTs
were coated with Curosurf (Chiesi, Parma, Italy), a well
characterized natural porcine surfactant preparation
[37-39]. The properties and the composition of Curosurf
are similar to human pulmonary surfactant and thus it
is widely used in the treatment or prophylaxis of the
neonatal respiratory distress syndrome [40-42]. By using
thin layer chromatography (TLC), it was shown that
patterns of MWCNT bound surfactant lipids were
identical to the patterns of the complete surfactant
(Figure 1A). This finding indicates an unspecific binding,
i.e. no influence of the functional groups, which may be
explained by the hydrophobic properties of the
MWCNTs. The coating of MWCNTs with pulmonary
surfactant components was confirmed with transmission
electron microscopy (TEM) (Figure 2). It was observed
that lipophilic surfactant components foster adhesion
among MWCNTs; a phenomenon that was also simi-
larly described in a previous study on carbon black [11].
Such an effect may become more relevant when
Table 1 Characterization of MWCNTs.
P-MWCNT MWCNT-NH2 MWCNT-COOH
Length [nm] 500 to >2000
External diameter [nm] 20 - 30
Specific surface area [m2/g] [67] 250-400
Number of side groups [22] [modifications/1000 nm length] - ~5000
Zeta-potential in H2O [mV] -2 +26 -57
Zeta-potential in plasma [mV] -23 -24 -24
Zeta-potential in Curosurf [mV] -63 -50 -56
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Figure 1 Identification of lipids and proteins bound to MWCNTs. A)TLC separation of bound lipid components. From left to right: Lipids
from pure Curosurf (CS), lipids bound to the P-MWCNT, MWCNT-NH2, MWCNT-COOH. Abbreviations for the lipids: TG Triglyceride, PG
Phosphatidylglycerol, PE Phosphatidylethanolamie, PS Phosphatidylserine, PI Phosphatidylinositol, PC Phosphatidylcholine, SM Sphingomyelin, PIP
Phosphatidylinositolphosphate. Lipid classes were allocated by comparisons to the literature [37,61] and in addition three of the most abundant
lipids (Phosphatidylcholine, Phosphatidylethanolamine, Phosphatidylglycerol) were confirmed by the use of standards (lanes 5-7). The arrow
points to the front of the first solvent. B) Lipids bound to P-MWCNT incubated in Curosurf and post-incubated in Roswell Park Memorial Institute
Medium (RPMI) and in blood plasma respectively. RPMI which was used as a control for cell culture medium did not alter the lipid patterns
which were obtained by pure Curosurf incubation. The arrow points to the front of the first solvent. C) Plasma proteins adsorbed on the
different functionalized MWCNTs separated by SDS-PAGE (left part) and quantified by densitometry (right part). 1. Alpha-2-macroglobulin
precursor; 2. Complement factor H; 3. Inter-alpha (globulin) inhibitors H1, H2, H4, Complement component 7, Plasminogen; 4. Gelsolin isoform c,
Cadherin-5; 5. Coagulation factor XI; 6. Keratin 6A. D) Effect of a Curosurf pre-incubation (P-MWCNT+CS) on the protein adsorption pattern.
Arrows point to characteristical bands. 1. Apolipoprotein A (precursor), Apolipoprotein B (precursor); 2. Unknown; 3. Ceruloplasmin; 4. Unknown;
5. Fibrinogen beta chain.
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MWCNTs get in a more hydrophilic environment (as it
may happen during a translocation into the hypophase)
and remain associated through hydrophobic forces.
To examine if lipid coatings undergo further dynamic
changes, MWCNTs were pre-incubated in Curosurf and
subsequently incubated in blood plasma. Figure 1B
shows that patterns of bound (surfactant) lipids were
clearly altered after subsequent plasma incubation. On
the one hand, characteristic lipids from blood (choles-
terol ester and triglycerides) were found to bind on
MWCNTs and on the other hand the appearance of
phosphatidylserine, a lipid from Curosurf, was less
pronounced.
If MWCNTs are internalized into cells, the specific
lipid coatings may have crucial consequences as the
molecular signature of the tube may be recognized more
as a biological structure with its distinct functions. In
addition to the roles lipids play in surfactant, they are
known for numerous other functions. Phosphatidylcho-
line or phosphatidylinositol for example are well known
to be involved in signaling. Only phosphatidylinositol
and phosphatidylinositolphosphates regulate the activity
of at least a dozen enzymes that control many key cellu-
lar functions, including differentiation, metabolism and
proliferation [43]. Definitive consequences of a possible
translocation of these lipids by CNTs to sites of action
are not fully understood and further investigations are
needed.
MWCNTs that reach the pulmonary blood circulation
can interact with numerous proteins. To investigate if
functionalization has a direct influence on the protein
patterns, plasma proteins bound to different MWCNTs
were identified. Figure 1C shows plasma proteins which
were bound to the different functionalized MWCNTs.
Six characteristic proteins, which were specific or clearly
pronounced for one type of MWCNT, were reproduci-
bly identified after separation by sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Mass
spectrometric (MS) investigations of the protein compo-
sition from specific bands revealed further that single
gel bands contain high numbers of bound proteins.
Nevertheless, characteristic proteins could be assigned
to the bands by including the number of detected pep-
tides and excluding proteins from outside the bands
weight range ("background”). Thus it was indicated that
there were different proteins binding to MWCNTs
which were not functionalized (P-MWCNT) compared
to both the positive MWCNT-NH2 and the negative
MWCNT-COOH. Such differences were more pro-
nounced between pristine and functionalized MWCNTs,
whereas among functionalized MWCNTs less variability
was found. Visual and densitometric (Figure 1C, right
section) analyses of the gels showed a noticeable trend
for heavier proteins (>100 kDa) on P-MWCNTs com-
pared to functionalized MWCNTs. Hence it can be
hypothesized that, at these conditions, surface charge
properties only play a minor role in contrast to steric
hindrance which prevents larger proteins to bind to
functionalized tubes - a phenomenon that is also
described in literature [25]. In contrast, smaller proteins
may be favored in such situations. Visual analyses were
supported by direct mass spectrometric analysis (addi-
tional file 1). The alteration in the protein coating from
MWCNTs that translocate across the alveolar epithe-
lium into the pulmonary circulation was simulated by
pre-coating the tubes with surfactant, followed by incu-
bation in blood plasma. The identification of five char-
acteristic proteins on P-MWCNTs (Figure 1D)
demonstrates that the pre-incubation of MWCNTs in
surfactant has an influence on the composition of
bound plasma proteins. Surprisingly, on P-MWCNTs
which were not pre-coated with surfactant, specific pro-
teins were found, which could not be found on pre-
coated ones. It can be hypothesized that these proteins
were not able to bind to pre-coated MWCNTs due to
altered hydrophobic interactions or steric hindrance by
the bound lipids. In contrast, proteins which are only
present on pre-coated MWCNTs may have two different
origins: either these are components of the surfactant
itself or they stem from blood plasma and interact speci-
fically with components of the bound surfactant. Phos-
phatidylethanolamim, for example, is known to build
hydrogen bonds to proteins through its ionizable amine
group. Moreover for phosphatidylinositol, specific bind-
ing to characteristic domains ("Pleckstrin homology or
PH domains”) of cellular proteins and unspecific binding
due to electrostatic interactions are known [43]. Inter-
estingly, less variability depending on the pre-coating
Figure 2 TEM image of P-MWCNTs which were coated with
Curosurf and subsequently washed. The scale bar is 0.5 μm.
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was detected in functionalized MWCNTs. This may be
due to decreased lipid binding to the functionalized
tubes in comparison to P-MWCNTs. Another reason
may be that similar steric hindrance is reached either by
pre-coating or by functionalization. This would impli-
cate that the surface properties of a functionalized
MWCNT are not changed to the same extent by pre-
coating as the surface properties of a P-MWCNT.
After identifying a number of specifically bound pro-
teins, their characteristic properties such as structure,
function, weight and isoelectric point were assessed. By
using this approach, it was possible to relate the functions
of bound proteins with the different conditions
(MWCNTs functionalization, surfactant pre-coating). Pro-
teins with a large variety of functions were found to be
associated with MWCNTs. Interestingly, apolipoproteins
of different types were detected in all conditions (addi-
tional file 1). These proteins are well known to bind to the
majority of nanoparticles [23,31,44]. In a study where high
amounts of apolipoprotein A-1 were found on copolymer
nanoparticles [31], the affinity to the hydrophopic particles
and the curvature of the particle were denoted as impor-
tant factors. As the MWCNTs used in the current study
had diameters similar to lipoprotein particles from blood,
the curvature of the MWCNTs could also be a main rea-
son for the increased binding. Apolipoproteins are consti-
tuents of lipoproteins and are responsible for the transport
of fats. They regulate the lipid metabolism and may be
involved in cardiovascular disease risk [45] and amyloido-
sis [46-48]. Furthermore, apolipoproteins seem to play an
important role in the transport of nano-sized particles
across the blood-brain barrier (BBB) [49,50] - this could
also be true for MWCNTs.
In contrast to the apolipoproteins, the most abundant
blood protein albumin was only detected on MWCNTs
that were not pre-coated with Curosurf (additional file
1). This indicates reduced binding of Albumin after
coating with the lipids. Albumin exhibits a less orga-
nized secondary structure upon adsorption onto a
hydrophobic surface [51]. By looking at the proteins
function, it was shown that albumin which was bound
to single-walled carbon nanotubes (SWCNTs) altered
the inflammatory response of RAW264.7 macrophages
by a reduction of LPS-mediated Cox-2 induction [20].
These indications would imply that bound Curosurf can
modulate the CNTs (pro-) inflammatory potential by a
reduction of albumin binding.
In addition, the fibrinogen beta chain binding
decreased due to Curosurf pre-coating on P-MWCNTs
and MWCNT-NH2 (Figure 1D and additional file 1).
Fibrinogen has a double function: yielding monomers
that polymerize into fibrin and acting as a cofactor in
platelet aggregation [52]. Interestingly it was shown that
the function of fibrinogen to mediate platelet
recognition, adhesion, activation, and aggregation was
significantly suppressed when it was adsorbed to
SWCNTs [53]. In this case we could expect a smaller
decrease in platelet aggregation after Curosurf coating.
Another important group of bound proteins are the
Complement components which play a key role in the
innate and adaptive immune response. Complement
components were found on all 3 types of MWCNTs
(additional file 1), however the Complement component
7 and the Complement factor H were found preferen-
tially on P-MWCNTs (Figure 1C). An activation of the
Complement system by CNTs via the classical and the
alternative pathway could be a consequence [54].
Characteristically bound to P-MWCNT was Alpha-2-
Macroglobulin (Figure 1C and additional file 1), which
is known to inhibit proteinases [52]; the calcium depen-
dent cell adhesion protein Cadherin [55] (Figure 1C);
Gelsolin (Figure 1C), an actin-modulating protein which
is Calcium-regulated [56]; Plasminogen (Figure 1C)
which dissolves (as Plasmin) the fibrin of blood clots
and acts as a proteolytic factor in various other pro-
cesses, such as in remodeling or inflammation [52]; and
the inter-alpha (globulin) inhibitors (Figure 1C) which
may act as a Hyaluronan carrier or binding protein [52].
Specifically bound to MWCNT-COOH was Keratin
6A (a constituent protein of the intermediate filaments)
and the coagulation factor XI (Figure 1C) (involved in
the intrinsic pathway of blood coagulation [57]), which
was also detected on MWCNT-NH2. Ceruloplasmin,
which has its main function in the transport of copper
[52,58], was only found on P-MWCNTs that were pre-
incubated in Curosurf. Numerous further functions can
be assigned to bound proteins (additional file 1).
Thereby it has to be taken into account that primary
protein functions can alter after binding due to confor-
mational change [22,51,59].
It was of great interest to determine if there are struc-
tural or functional similarities among proteins which are
bound to MWCNTs of one condition (functionalization
or Curosurf pre-coating). Thus, the study aimed to iden-
tify characteristic regions by a sequence alignment of the
proteins’ amino acids. These analyses did not identify a
common sequence of amino acids within proteins which
were bound to MWCNTs in one condition. Also an ana-
lysis of the total charge (isoelectric point) of different
proteins did not reveal a tendency. Thus various proteins
with very distinct structures bind to the three types of
MWCNT tested without any identifiable pattern, indicat-
ing that MWCNT were able to adsorb proteins in an
unspecific manner or not by a single mechanism only.
Conclusions
It was shown that lipids and proteins, which are consti-
tuents of the air-blood tissue barrier, bind to MWCNTs
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(Figure 3). Thus the characteristics of MWCNTs change
as soon as they are deposited onto the lung surface. Dif-
ferent functionalized MWCNTs are coated similar with
lung surfactant lipids which alter the chemical and phy-
sical state of the tubes. This first stage coating has sev-
eral effects on the subsequent blood plasma protein
coating (Figure 3C): Firstly, proteins of the surfactant
itself bind to the CNTs [21], secondly, bound lipids
seem to enable binding of certain plasma proteins and
thirdly, other plasma proteins may be sterically hindered
to bind by the presence of surfactant components. Like
proteins, lipids also undergo dynamic exchange pro-
cesses and there are strong indications that the compo-
sition of bound surfactant lipids is changed, at the latest,
when MWCNTs come in contact with blood plasma
lipids. With respect to experimental settings, these
results point to the importance of considering the sur-
factant coating in in vitro lung models. A way to include
this issue is to work with air-liquid interface models
[60].
Besides the surfactant pre-coating, the functionaliza-
tion of the MWCNT was identified as an influencing
factor for plasma protein binding (Figure 3B). Thereby
the type of functionalization (amino or carboxyl group)
seems to play a minor role in contrast to the alteration
in hydrophobicity or steric hinderance that results from
the functionalization. The latter factor might also be the
reason for the increased binding of larger proteins to
MWCNTs which were not functionalized. The proteins
adsorbed to the surface of the tubes trigger numerous
eminent functions, for example they are involved in
transport and uptake mechanisms of nano-sized parti-
cles or fulfill functions in the immune system. Although
consequences on molecular and cellular levels can be
estimated, an uncertainty remains as new functions can
be expected from bound proteins. With this characteri-
zation, a first important step is done and these new
findings can be related to toxicology and uptake data
with further experiments.
Future focus should be on the possible relationships
between the so called “cryptic epitopes” [30] and the
cellular effects upon exposure. Hence only by the
knowledge of the coronas composition might adverse
effects be assessed (the “epitope map” [30]). With such
an approach it could be possible to assess adverse effects
of nano-objects more easily and to rapidly recommend
safety measures to industry.
Methods
MWCNTs production and characterization
MWCNTs were synthesized by chemical vapor deposi-
tion from Chengdu Carbon Nanomaterials R&D Center
(Sichuan, China) and functionalized as previously
reported [28]. The Zeta-potential was measured with a
Malvern Zetasizer (Malvern Instruments Ltd, Worces-
tershire, United Kingdom). TEM was performed by a
Philips 300 TEM at 60 kV (FEI Company Philips Elec-
tron Optics, Zurich, Switzerland).
Characterization of bound pulmonary surfactant lipids
MWCNTs were dispersed (20 mg/ml) in Curosurf 120
(Chiesi, Parma, Italy), a lipid-based surfactant from pigs.
Dispersions were sonicated in a cooled Sonorex RK 156
BH (Bandelin, Berlin, Germany) water bath for 15 min-
utes. After 24 h of incubation at 37°C, MWCNTs were
washed 4 times with phosphate buffered saline (PBS)
and centrifuged at a low speed (500 g). Thin layer chro-
matography (TLC) was performed for the separation of
surfactant lipids that were bound to the MWCNTs. The
pellet was dispersed in the resolving agent (CHCl3/
MeOH [2:1]) and 20 μl were pipetted onto a silica gel
plate (Merck, Darmstadt, Germany). Pure Curosurf
which was diluted (1:10), Phosphatidylcholine, Phospha-
tidylethanolamine and Phosphatidylglycerol (all from
Sigma-Aldrich, Buchs, Switzerland) were dissolved
(2 mg/ml) in the resolving agent and used as standards.
For improved visualization, two solvents (CHCl3/
MeOH/HAc/H2O [56:33:9:2] and Hexan/Ether/HAc
[80:20:1]) were applied [61]. After the chromatographical
separation, the plate was placed in a 8%v/v H3PO4 /10%
m/v CuSO4 solution and left to develop at 180°C for
about 5 min.
Characterization of bound proteins
MWCNTs in blood plasma (200 μg/ml) were sonicated
for 15 min and incubated for 24 h at 37°C. MWCNTs
used for a two step coating were pre-coated with Curo-
surf as described above, washed 3 times with PBS and
then the blood plasma was added (200 μg/ml). After 15
min of sonication, MWCNTs were incubated for
another 24 h at 37°C and washed 4 times with PBS. Pro-
teins were either directly analyzed by liquid chromato-
graphy/tandem mass spectrometry (LC/MS/MS, see
Figure 3 The binding of blood plasma proteins to MWCNTs
under different conditions. A) Blood plasma protein coating on P-
MWCNT. B) The protein pattern is altered when MWCNTs are
functionalized. C) A further alteration effect is observed when lipids
from surfactant are bound to the MWCNTs. A selection of detected
proteins are shown (models adapted from SWISS-MODEL [64-66]
and proteinmodelportal.org).
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below) or detached by adding 6-times concentrated
SDS-loading buffer for sodium dodecylsulfate polyacryla-
mide gel electrophoresis (SDS-PAGE). Proteins were
visualized with a Dodeca Silver Stain Kit (Bio-Rad,
Reinach, Switzerland) and with a Sypro Ruby Stain Kit
(Bio-Rad, Reinach, Switzerland), respectively. Intensities
of stained proteins were quantified by the Bio-Rad
Quantity One Software on the Fluor-S MultiImager sys-
tem. Bands that were characteristically found in at least
3 repetitions were cut out and analyzed by LC/MS/MS
after Trypsin digestion. All LC/MS/MS samples were
analyzed using Mascot (Matrix Science, London, United
Kingdom; version Mascot). Mascot was set up to search
the NCBInr_20090524 database (selected for Homo
sapiens, unknown version, 222717 entries). Scaffold (ver-
sion Scaffold_2_06_00, Proteome Software Inc., Port-
land, USA) was used to validate LC/MS/MS based
peptide and protein identifications. Peptide identifica-
tions were accepted if they could be established at
greater than 95.0% probability as specified by the Pep-
tide Prophet algorithm [62]. Protein identifications were
accepted if they could be established at greater than
99.9% probability and contained at least 2 identified
peptides. Protein probabilities were assigned by the Pro-
tein Prophet algorithm [63]. Sequences of characteristi-
cally bound amino acids were compared by an online
alignment function [52].
Additional material
Additional file 1: Proteins detected ("X”) with direct LC/MS/MS.
Bound proteins which were detected by LC/MS/MS without previous
separation by SDS-PAGE.
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